NCT03542786 (RECOVER) is a NA clinical trial of Probiotic in HIV, sponsored by AB Biotics, SA.

Who is sponsoring NCT03542786?

NCT03542786 is sponsored by AB Biotics, SA.

What drugs are being tested in NCT03542786?

Interventions in NCT03542786: Probiotic, Prebiotic, Placebo.

What condition does NCT03542786 study?

NCT03542786 studies HIV, Premature Aging.

Is NCT03542786 still recruiting?

NCT03542786 is currently completed. Last updated 8 July 2020.

Last reviewed 2020-07-08 · How we verify

NCT03542786: RECOVER

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial to Evaluate the Addition to an Antiretroviral Treatment of a Probiotic

Completed NA Last updated 8 July 2020

What this trial tests

NA trial testing Probiotic in HIV in 89 participants. Completed in 29 February 2020.

Timeline

18 December 2017

Primary endpoint
29 February 2020

29 February 2020

Quick facts

Lead sponsor	AB Biotics, SA
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	89
Start date	18 December 2017
Primary completion	29 February 2020
Estimated completion	29 February 2020
Sites	1 location across Spain

Drugs / interventions tested

Probiotic
Prebiotic — full drug profile →
Placebo

Conditions studied

HIV — all drugs for HIV →
Premature Aging — all drugs for Premature Aging →

Sponsor

AB Biotics, SA — full company profile →

Who can join

18 and older, any sex, with HIV or Premature Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main purpose of this study is to evaluate a therapy for the inflammaging (premature aging).

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

β-Glucan Metabolic and Immunomodulatory Properties and Potential for Clinical Application.
Murphy EJ, Rezoagli E, Major I, Rowan NJ, et al · · 2020 · cited 121× · PMID 33322069 · DOI 10.3390/jof6040356
Probiotic effects on immunity and microbiome in HIV-1 discordant patients.
Blázquez-Bondia C, Parera M, Català-Moll F, Casadellà M, et al · · 2022 · cited 18× · PMID 36569851 · DOI 10.3389/fimmu.2022.1066036
Lights and Shadows of Microbiota Modulation and Cardiovascular Risk in HIV Patients.
Villoslada-Blanco P, Pérez-Matute P, Oteo JA. · · 2021 · cited 4× · PMID 34202210 · DOI 10.3390/ijerph18136837

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

NCT07529457 — Akk09 in Adults With Constipation · NA · not yet recruiting
NCT07507955 — Probiotics for Constipation Relief in Adults · NA · not yet recruiting
NCT07462481 — Probiotic Improve Constipation · NA · recruiting
NCT07511855 — Stress-buffering and Sleep Disturbance-resilient Effects of a Dual Bifidobacterium Longum Combination Under Short-term T · Phase 2 · not yet recruiting
NCT07474064 — Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC · Phase 2 · not yet recruiting

Other recruiting trials for HIV

Currently open trials in the same condition.

NCT06705478 — Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disor · Phase 2 · recruiting
NCT07221214 — GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV · Phase 2 · recruiting
NCT07226128 — The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV · NA · recruiting
NCT07390474 — Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA i · Phase 1 · recruiting
NCT07390955 — A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1 · Phase 1 · recruiting

Other AB Biotics, SA trials

Trials by the same sponsor.

NCT07193927 — Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Diseas · Phase 2 · not yet recruiting
NCT06604234 — Impact of a Probiotic Combination on Quality of Life and Symptoms in Peri- and Postmenopausal Women · NA · completed
NCT06193096 — Impact of a Probiotic-based Formula on Digestive Symptoms and Mood in Ultra Marathon Runners · NA · completed
NCT05688397 — Evaluation of the Vaginal Colonization of Two New Lactobacillus Strains After Oral Administration in Healthy Volunteers · NA · completed
NCT05524649 — Effect of Probiotics on Infant's Fecal Microbiota Composition · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03542786 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AB Biotics, SA
Last refreshed: 8 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03542786.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing